Skip To Main Content
Heike Haenel on Muck Rack

Heike Haenel

As seen in: BioRxiv, Genome Research
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Heike

Contact Heike, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects of SF3B1 mutations

|
By Alicja Pacholewska, Matthias Lienhard, Mirko Brueggemann, Heike Haenel
| Genome Research
1,12 1 University of Cologne, Medical Faculty and University Hospital Cologne, Institute for Translational Epigenetics; 2 Max Planck Institute for Molecular Genetics; 3 Buchmann Institute for Molecular Life Sciences; 4 Institute of Molecular Biology (IMB); 5 University of Cologne, Medical Faculty and University Hospital of Cologne, Institute for Translational Epigenetics; 6 Heinrich Heine University Duesseldorf; 7 Heinrich Heine University Duesseldorf, Institute for Pharmaceutical and...
Open in Who Shared Issue with article?

Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects of SF3B1 mutations

|
By Alicja Pacholewska, Matthias Lienhard, Mirko Brueggemann, Heike Haenel
| BioRxiv
Abstract Background: Mutations in splicing factor 3B subunit 1 (SF3B1) frequently occur in patients with chronic lymphocytic leukemia (CLL) and myelodysplastic syndromes (MDS). These mutations have a different effect on the disease prognosis with beneficial effect in MDS and worse prognosis in CLL patients. A full-length transcriptome approach can expand our knowledge on SF3B1 mutation effects on RNA splicing and its contribution to patient survival and treatment options.
Open in Who Shared Issue with article?
See all 2 articles